High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease

Pneumologia

Volumn 61, Issue 3, 2012, Pages 160-162

  Tofan, Fatmeh ^a   Rahimi Rad, Mohammad Hossein ^a,c   Rasmi, Yosef ^a   Rahimirad, Shagayeg ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Hs CRP; Outcome; Prediction

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ACUTE DISEASE; AGED; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME; UNIVERSITY HOSPITAL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84871905284     PISSN: 20672993     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/. 2011.
2. Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. Mar 2003; 123(3):784-791.
3. Ruiz-Gonzalez A, Lacasta D, Ibarz M, Martinez-Alonso M, Falguera M, Porcel JM. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology. Nov 2008; 13(7):1028-1033.
4. Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. Jul 2003; 14(7):1871-1879.
5. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. Mar 2000; 35(3):469-476.
6. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke. Oct 2002; 33(10):2459-2464.
7. Presterl E, Staudinger T, Pettermann M, et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med. Sep 1997;156(3 Pt 1):825-832.
8. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg. Feb 1989; 76(2):177-181.
9. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. Aug 2003; 124(2):459-467.
10. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. Aug 2005; 26(2):234-241.
11. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. Apr 3 2001; 103(13):1813-1818.
12. Takemura M, Matsumoto H, Niimi A, et al. High sensitivity C-reactive protein in asthma. Eur Respir J. May 2006; 27(5):908-912.
13. Tracy RP. Inflammation in cardiovascular disease: cart, horse, or both? Circulation. May 26 1998; 97(20):2000-2002.
14. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem. Mar 2001; 47(3):418-425.
15. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. Dec 8 1999; 282(22):2131-2135.
16. Kompoti M, Drimis S, Papadaki A, et al. Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. Eur J Intern Med. Jun 2008; 19(4):261-265.
17. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. May 2006; 27(5):902-907.
18. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. Aug 2009; 103(8):1231-1238.
19. Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med. Apr 1998; 92(4):664-667.
20. Aaron SD, Vandemheen KL, Ramsay T, et al. Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD. Respir Res. 2010; 11:41.